4. Net investment income
In € thousand |
Property and casualty insurance |
Health insurance |
Life insurance |
Total |
||||
---|---|---|---|---|---|---|---|---|
1–12/2019 |
1–12/2018 |
1–12/2019 |
1–12/2018 adjusted |
1–12/2019 |
1–12/2018 |
1–12/2019 |
1–12/2018 adjusted |
|
Investment property |
15,278 |
9,117 |
12,983 |
9,621 |
54,047 |
32,475 |
82,308 |
51,213 |
Financial assets accounted for using the equity method |
7,601 |
58,565 |
22,153 |
19,553 |
34,674 |
31,071 |
64,428 |
109,189 |
Variable-income securities |
4,422 |
16,450 |
9,576 |
9,022 |
1,487 |
19,284 |
15,484 |
44,756 |
Available for sale |
6,333 |
14,807 |
8,861 |
8,902 |
1,185 |
19,194 |
16,379 |
42,903 |
At fair value through profit or loss |
–1,912 |
1,642 |
715 |
120 |
302 |
90 |
–894 |
1,853 |
Fixed-income securities |
119,094 |
77,511 |
69,321 |
83,104 |
247,904 |
253,456 |
436,319 |
414,071 |
Available for sale |
112,090 |
81,459 |
60,868 |
85,447 |
247,768 |
252,528 |
420,726 |
419,434 |
At fair value through profit or loss |
7,004 |
–3,948 |
8,454 |
–2,343 |
136 |
928 |
15,593 |
–5,363 |
Loans and other investments |
6,033 |
3,667 |
3,932 |
2,092 |
26,879 |
34,174 |
36,843 |
39,933 |
Loans |
967 |
450 |
1,637 |
1,754 |
6,394 |
10,142 |
8,999 |
12,345 |
Other investments |
5,066 |
3,217 |
2,294 |
339 |
20,485 |
24,032 |
27,845 |
27,588 |
Derivative financial instruments |
–10,416 |
–16,586 |
311 |
–10,485 |
422 |
–918 |
–9,682 |
–27,989 |
Investment administration expenses, interest paid and other investment expenses |
–19,935 |
–20,579 |
–9,241 |
–9,528 |
–11,280 |
–16,037 |
–40,456 |
–46,144 |
Total |
122,077 |
128,145 |
109,034 |
103,379 |
354,133 |
353,505 |
585,244 |
585,029 |
|
|
|
|
|
|
|
|
|
Of which: |
|
|
|
|
|
|
|
|
Current income/expenses |
107,685 |
107,340 |
86,621 |
83,623 |
336,775 |
336,692 |
531,081 |
527,656 |
Gains/losses from disposals and changes in value |
14,391 |
20,805 |
22,414 |
19,756 |
17,358 |
16,813 |
54,163 |
57,374 |
Impairments |
–11,992 |
–13,062 |
–6,941 |
–1,280 |
–3,204 |
–15,650 |
–22,138 |
–29,992 |
In € thousand |
Current income/expenses |
Gains/losses from disposals and changes in value |
Total |
of which impairment |
||||||
---|---|---|---|---|---|---|---|---|---|---|
1–12/2019 |
1–12/2018 |
1–12/2019 |
1–12/2018 adjusted |
1–12/2019 |
1–12/2018 adjusted |
1–12/2019 |
1–12/2018 |
|||
|
||||||||||
Financial assets at fair value through profit or loss |
1,414 |
2,124 |
3,603 |
–33,624 |
5,017 |
–31,500 |
0 |
0 |
||
Variable-income securities (within the framework of fair value option) |
595 |
763 |
–1,490 |
1,090 |
–894 |
1,853 |
0 |
0 |
||
Fixed-income securities (within the framework of fair value option) |
2,572 |
1,510 |
13,022 |
–6,873 |
15,593 |
–5,363 |
0 |
0 |
||
Derivative financial instruments |
–1,752 |
–149 |
–7,930 |
–27,841 |
–9,682 |
–27,989 |
0 |
0 |
||
Investments under investment contracts1) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
||
390,453 |
392,045 |
46,651 |
70,292 |
437,104 |
462,337 |
–20,258 |
–12,980 |
|||
Variable-income securities |
29,015 |
36,555 |
–12,636 |
6,348 |
16,379 |
42,903 |
–12,385 |
–10,175 |
||
Fixed-income securities |
361,438 |
355,490 |
59,287 |
63,944 |
420,726 |
419,434 |
–7,873 |
–2,805 |
||
Loans and receivables |
37,234 |
39,116 |
–391 |
817 |
36,843 |
39,933 |
–32 |
–89 |
||
Fixed-income securities |
5,959 |
7,921 |
–349 |
1,272 |
5,610 |
9,193 |
0 |
0 |
||
Loans and other investments |
31,275 |
31,195 |
–42 |
–455 |
31,233 |
30,740 |
–32 |
–89 |
||
Investment property |
78,007 |
78,781 |
4,300 |
–27,568 |
82,308 |
51,213 |
–1,848 |
–16,923 |
||
Financial assets accounted for using the equity method |
64,428 |
61,733 |
0 |
47,456 |
64,428 |
109,189 |
0 |
0 |
||
|
|
|
|
|
|
|
|
|
||
Investment administration expenses, interest paid and other investment expenses |
–40,456 |
–46,144 |
0 |
0 |
–40,456 |
–46,144 |
0 |
0 |
||
Total |
531,081 |
527,656 |
54,163 |
57,374 |
585,244 |
585,029 |
–22,138 |
–29,992 |
In € thousand |
1–12/2019 |
1–12/2018 |
---|---|---|
Current income/expenses from investment property |
|
|
Rent revenue |
108,418 |
110,491 |
Operational expenses |
–30,411 |
–31,710 |
Gains/losses from disposals and changes in value |
|
|
Currency gains/losses |
–17,701 |
–16,603 |
of which gains/losses from derivative financial instruments as part of US dollar underlying |
3,547 |
8,620 |
of which gains/losses from derivative financial instruments as part of hedge transactions in US dollar |
–7,755 |
–11,965 |
Positive currency effects from investments amounting to €1,304 thousand (2018: positive currency effects amounting to €9,558 thousand) were recognised directly in equity.
In € thousand |
1–12/2019 |
1–12/2018 |
---|---|---|
Financial assets at fair value through profit or loss |
|
|
Recognised in profit/(loss) for the period |
5,017 |
–31,500 |
Available-for-sale financial assets |
|
|
Recognised in profit/(loss) for the period |
437,104 |
462,337 |
of which reclassified from equity to consolidated income statement |
–46,216 |
–99,926 |
Recognised in other comprehensive income |
957,411 |
–445,017 |
Net income |
1,394,515 |
17,320 |
Loans and receivables |
|
|
Recognised in profit/(loss) for the period |
36,843 |
39,933 |
Financial liabilities measured at amortised cost |
|
|
Recognised in profit/(loss) for the period |
–54,643 |
–52,800 |